Dr. Christopher Heaphy

Biography

Dr. Christopher Heaphy is a dedicated cancer biologist whose research integrates tissue-based, cell-based, and molecular approaches to investigate the role of telomere alterations in human diseases, with a primary focus on cancer, particularly prostate cancer, pancreatic neuroendocrine tumors, breast cancer, sarcomas, and gliomas. His laboratory conducts both basic and translational research aimed at understanding the alterations that contribute to the initiation and progression of cancer. The overarching goal of Dr. Heaphy's research program is to leverage molecular insights from the tumor microenvironment to advance clinical applications. He aims to develop strategies for accurately predicting cancer risk, prognosis, and potential responses to targeted therapies. Dr. Heaphy earned his Ph.D. from the University of New Mexico School of Medicine and completed postdoctoral training at the Johns Hopkins University School of Medicine. He is currently an Associate Professor of Medicine affiliated with Boston Medical Center and is a member of the Boston University-Boston Medical Center Cancer Center. His dedication to diversity, equity, and inclusion is evident in his support for various initiatives aimed at fostering equity in healthcare and education, particularly for historically underrepresented groups in medical science.

Research Interests

Experience